%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
2013-08-06T18:24:45+03:00
2013-08-06T18:24:45+03:00
2013-08-06T18:24:45+03:00
application/pdf
bs-9934R-Cy3
uuid:4e72494c-890c-47b3-86f3-8946922a0832
uuid:ff478616-6126-46c4-bcb5-c030688746a8
Acrobat Web Capture 9.0
endstream
endobj
5 0 obj
<>
endobj
6 0 obj
<>
endobj
3 0 obj
<>
endobj
7 0 obj
<>
endobj
11 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC/ImageI]/XObject<>>>/Type/Page>>
endobj
12 0 obj
[29 0 R]
endobj
13 0 obj
<>stream
/CS0 cs 1 scn
10 815.54 574.5 -714.418 re
f
BT
0.2 scn
/TT0 1 Tf
6.4478 0 0 6.4478 20.9613 768.4714 Tm
(www.biossusa.com)Tj
0 -1.5 TD
(support@biossusa.com)Tj
-0.012 Tw 0 -1.5 TD
[(800.501.7654)-34( )1([DOMESTIC])]TJ
0 -1.5 TD
[(+1.781.569.5821)-57( )1([INTERNATIONAL])]TJ
ET
q
/GS0 gs
137.3383942 0 0 -77.3737335 447.1616364 810.3821716 cm
/Im0 Do
Q
BT
0 scn
/TT1 1 Tf
0 Tw 9.0269 0 0 9.0269 20.9613 718.1785 Tm
[(bs)-67(-)-69(9934R)-12(-)-69(Cy3)]TJ
/TT0 1 Tf
-0.04 Tw 7.0926 0 0 7.0926 22.2508 673.0438 Tm
[(Conjugated)-58( Primary)-1( Antibodies)]TJ
/TT1 1 Tf
0 Tw 0 -2.091 TD
(Background:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(HARBI1)-50( is)-52( a)-20( 349)-89( amino)-32( acid)-50( nuclear)-56( and cytoplasmic)-63( protein)-79( belonging)-62( to)-32( the)-37( HARBI1)-50( family.)-58( Members)-69( of)-48( the)]TJ
0 -1.455 TD
[(HARBI1)-50( family)-88( of)-48( proteins)-87( are)-43( highly)-11( conserved)-74( in)-31( humans)-60( to)-32( various)-23( bony)-30( fish.)-55( Considered)-14( a)-20( transposase)-11(-)]TJ
0 -1.455 TD
[(derived)-28( protein,)-49( HARBI1)-51( may)-46( possess)-48( nuclease)-80( activity)-74( and is)-52( expressed)-23( in)-31( brain,)-17( eye,)-56( nerve)-77( tissue,)-67( kidney)-47( and)]TJ
0 -1.455 TD
[(lung.)-72( HARBI1)-51( utilizes)-5( divalent)-3( metal)-1( cations)-86( as)-29( cofactors,)-70( interacts)-45( with)-46( NAIF1)-20( and promotes)-37( translocation)-82( to)-32( the)]TJ
0 -1.455 TD
[(nucleus.)-88( HARBI1)-50( is)-52( encoded)-7( by)-40( a)-20( gene)-19( located)-11( on)-81( human)-52( chromosome)-67( 11,)-59( which)-88( houses)-14( over)-73( 1,400)-58( genes)-27( and)]TJ
0 -1.455 TD
[(comprises)-51( nearly)-31( 4%)-22( of)-48( the)-36( human)-52( genome.)-60( Jervell)-33( and Lange)-67(-)-1(Nielsen)-1( syndrome,)-9( Jacobsen)-62( syndrome,)-9( Niemann)-6(-)]TJ
0 -1.455 TD
[(Pick)-79( disease,)-82( hereditary)-76( angioedema)-76( and Smith)-27(-)-1(Lemli)-42(-)-1(Opitz)-5( syndrome)-40( are)-43( associated)-48( with)-46( defects)-18( in)-31( genes)-27( that)]TJ
0 -1.455 TD
[(maps)-90( to)-32( chromosome)-67( 11.)]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Purification:)Tj
/TT0 1 Tf
-0.04 Tw 6.727 -0.091 Td
[(Was)-36( purified)-38( by)-40( Protein)-81( A)-36( and peptide)-90( affinity)-82( chromatography.)]TJ
/TT1 1 Tf
0 Tw -6.727 -2 Td
(Storage:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(Prepared)-46( as)-29( lyophilized)-45( powder)-87( or)-6( liquid)-13( and shipped)-37( on)-81( ice.)-26( Store)-44( at)-50( -)-1(20\260C)-18( for)-52( one)-9( year.)-61( Protect)-73( from)-30( light.)]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Reconstitution:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(If)-36( the)-36( antibody)-25( is)-52( in)-31( liquid)-13( form,)-91( no)-81( reconstitution)-78( needed.)]TJ
0 -2.909 TD
[(Reconstitution)-90( is)-52( only)-81( required)-62( for)-52( the)-37( lyophilized)-45( antibody.)-86( Please)-15( refer)-92( to)-32( the)-36( reconstitution)-78( instruction)-26( card)-10( in)]TJ
0 -1.455 TD
[(the)-37( package.)]TJ
/TT1 1 Tf
0 Tw 53.545 29.818 Td
(Size:)Tj
/TT0 1 Tf
-0.04 Tw 3 -0.091 Td
[(100ul)-29( or)-6( 100ug)-69( lyophilized)]TJ
/TT1 1 Tf
0 Tw -3 -2.818 Td
(Concentration:)Tj
/TT0 1 Tf
8.091 -0.091 Td
(1ug/uL)Tj
/TT1 1 Tf
-8.091 -2.818 Td
(Host:)Tj
/TT0 1 Tf
3.273 -0.091 Td
(Rabbit)Tj
/TT1 1 Tf
-3.273 -1.909 Td
(Reactivities:)Tj
0.2 scn
/TT0 1 Tf
6.4478 0 0 6.4478 402.0269 628.5539 Tm
(Human,Mouse,Rat,Chicken,Dog,Pig,Cow,Horse,Rabbit,Sheep,)Tj
0 scn
/TT1 1 Tf
7.0926 0 0 7.0926 402.0269 615.0135 Tm
(Application:)Tj
ET
q
10 36 575 780 re
W n
q 1 0 0 1 411.6987 597.9268 cm
0 0 m
0 1.29 -1.934 1.29 -1.934 0 c
-1.934 -1.29 0 -1.29 0 0 c
f
Q
Q
BT
/TT0 1 Tf
7.0926 0 0 7.0926 418.1465 596.3148 Tm
[(IF\(1:50)-4(-)-1(200\))]TJ
ET
q
10 36 575 780 re
W n
q 1 0 0 1 411.6987 587.6103 cm
0 0 m
0 1.29 -1.934 1.29 -1.934 0 c
-1.934 -1.29 0 -1.29 0 0 c
f
Q
Q
BT
/TT0 1 Tf
-0.04 Tw 7.0926 0 0 7.0926 418.1465 585.9984 Tm
[(Not)-1( yet)-6( tested)-8( in)-31( other)-43( applications.)-57( Optimal)]TJ
T*
[(working)-62( dilutions)-48( must)-4( be)-12( determined)-86( by)-40( the)-37( end)]TJ
0 Tw 0 -1.455 TD
(user.)Tj
/TT1 1 Tf
-0.02 Tw -2.273 -3.818 Td
[(Antibody)-48( Type:)]TJ
/TT0 1 Tf
0 Tw 8.182 -0.091 Td
(Polyclonal)Tj
/TT1 1 Tf
-8.182 -1.909 Td
(Isotype:)Tj
0.2 scn
/TT0 1 Tf
6.4478 0 0 6.4478 443.9377 524.0993 Tm
(IgG)Tj
0 scn
/TT1 1 Tf
-0.02 Tw 7.0926 0 0 7.0926 402.0269 510.5589 Tm
[(Molecular)-1( Weight:)]TJ
0.2 scn
/TT0 1 Tf
0 Tw 6.4478 0 0 6.4478 478.7559 510.5589 Tm
(39kDa)Tj
0 scn
/TT1 1 Tf
7.0926 0 0 7.0926 402.0269 497.0185 Tm
(Preservatives:)Tj
0.2 scn
/TT0 1 Tf
-0.012 Tw 6.4478 0 0 6.4478 464.5707 497.0185 Tm
[(10ug/uL)-59( )1(BSA)-54( )1(and)-64( )1(0.1%)-28( )1(NaN3.)]TJ
0 scn
0.021 Tw 5.803 0 0 5.803 402.0269 470.5825 Tm
[(For)-20( )1(research)-16( )1(use)-26( )1(only.)-91( )1(CAUTION:)-12( )1(Not)-11( )1(for)-1( )1(human)-72( )1(or)-97( )1(animal)]TJ
0 -1.333 TD
[(therapeutic)-36( )1(or)-97( )1(diagnostic)-13( )1(use.)]TJ
ET
q
/GS0 gs
548.0639801 0 0 -0.6447754 25.4747467 709.7963104 cm
/Im1 Do
Q
BT
/TT0 1 Tf
0 Tw 10.3165 0 0 10.3165 15.1582 103.0572 Tm
( )Tj
ET
q
10 36 575 780 re
W n
/CS3 cs 0.302 0.306 0.333 scn
q 1 0 0 1 13.2239 694.9663 cm
0 0 m
0 1.719 -2.579 1.719 -2.579 0 c
-2.579 -1.719 0 -1.719 0 0 c
f
Q
Q
BT
/CS3 cs 0.302 0.306 0.333 scn
/TT1 1 Tf
-0.007 Tw 9.0269 0 0 9.0269 22.2508 692.3872 Tm
[(Rabbit)-50( Anti)-28(-)-69(C11ORF77/HARBI1)-7( Polyclonal)-4( Antibody,)-47( Cy3)-49( conjugated)]TJ
/CS0 cs 0 scn
/TT0 1 Tf
0 Tw 10.3165 0 0 10.3165 19.0269 387.4057 Tm
( )Tj
12 0 Td
( )Tj
12 0 Td
( )Tj
-24 -2.25 Td
( )Tj
12 0 Td
( )Tj
12 0 Td
( )Tj
-24 -2.25 Td
( )Tj
12 0 Td
( )Tj
12 0 Td
( )Tj
-0.04 Tw 7.0926 0 0 7.0926 20.3165 310.032 Tm
[(For)-31( full)-30( size)-82( images)-63( and description)-26( please)-13( click)-31( )]TJ
/CS3 cs 0 0.6 0.8 scn
0 Tw 6.4478 0 0 6.4478 169.9057 310.032 Tm
(HERE)Tj
/CS0 cs 0 scn
7.0926 0 0 7.0926 186.0253 310.032 Tm
(.)Tj
ET
q
/GS0 gs
0.6447754 0 0 -580.3030396 389.7761078 709.1515045 cm
/Im2 Do
Q
q
/GS0 gs
5.8030243 0 0 -39.3316498 578.696991 140.4545288 cm
/Im3 Do
Q
endstream
endobj
14 0 obj
<>
endobj
15 0 obj
(n0_\)a8A4)
endobj
25 0 obj
<>stream
Hy\E323#3
P̴,HLEK"+E+2VTD%EH# }wfwfvvc_3?{feޝ@HHHHHH*豘V]
zן)@-9.q2BÇEڂ8g "2vn>u2]/Yz \S@ 7.M&p?o9v 0'rKś-;(Au.J%% %&˶0>6`TxOzzo(VDY*AZp ËgAs^.㮌+2Ȱ$E['FC:OMCIVVDD3}`u߈buߨɴ4қԭV^V0XF ϓ@i|Y|.?i'3}Ŵ+ޘaa:
3g},F"kNɳՕx57,H)X7*v/Mո+(fWr=WӃJcߓtG16sPt:t"9G
if
3do\ˢ|c:1&<ЭWnPdq0IRgu~惘n9BWV2T6~}rs4h-D.sgV/n3;q@hThI*jTJqJK2c!QT7;60
5NoJݻ'rBP%ȍ4
P(/CJC1
9eڴ}5S{"wty@P5e*Zg~?S(Sɗ,ʽv 2[̋t_Z\d&}/2YϹO&y#
?P>,0P-
asds[U꼩\=T~)S>B,gk$7+j0?60<&uźg
A]_@en%Mȝ~5PSu$^2s0RSPw L9٦n9$vڣ=f#g 7,Oa
:ܾ.4+H!=MvF(G|YU
ITR)>@✧*[j5KoB{Kp,`姙$JO궒jvż@r3`w\A%jSx+>m;5ا@._1:T#q]wrTC8r:lU4P}~Y]XwJ~b:YQϗLP-X_ֻа2$ݥC=~P]VҘLhu?S'\C:7"4dD*%9 Ogfe\OLoTy5Qkj.84,: t:_YON3˃:O/r犁3t!Psbty{aETu7nMѶ f+^Y6zHic?R%+C,γL =ZJ1H+,x^
I!u2{5x_@LI6[w5LN5:xXoEgf9tu=yùw=aґza*҃K`驪eP/y*sσn3N{ME\8g: *fz#W??L